In fact, in vitro studies [162] showed that pasireotide significantly inhibited ACTH secretion from primary cultures of human ACTH-secreting pituitary adenomas, while clinical studies have shown that pasireotide can reduce urinary free cortisol levels in patients with Cushing's disease [163]. Here, POMC is linked to pituitary gland adenoma.